These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30142326)

  • 1. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells.
    Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N
    Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
    Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
    Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.
    Pahle J; Menzel L; Niesler N; Kobelt D; Aumann J; Rivera M; Walther W
    BMC Cancer; 2017 Feb; 17(1):129. PubMed ID: 28193196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
    Casagrande F; Cocco E; Bellone S; Richter CE; Bellone M; Todeschini P; Siegel E; Varughese J; Arin-Silasi D; Azodi M; Rutherford TJ; Pecorelli S; Schwartz PE; Santin AD
    Cancer; 2011 Dec; 117(24):5519-28. PubMed ID: 21692061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.
    Sonoda N; Furuse M; Sasaki H; Yonemura S; Katahira J; Horiguchi Y; Tsukita S
    J Cell Biol; 1999 Oct; 147(1):195-204. PubMed ID: 10508866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy.
    English DP; Santin AD
    Int J Mol Sci; 2013 May; 14(5):10412-37. PubMed ID: 23685873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer.
    Gabig TG; Waltzer WC; Whyard T; Romanov V
    Biochem Biophys Res Commun; 2016 Sep; 478(2):887-92. PubMed ID: 27520378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin.
    Li X; Saeki R; Watari A; Yagi K; Kondoh M
    Eur J Pharm Sci; 2014 Feb; 52():132-7. PubMed ID: 24231339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin.
    Litkouhi B; Kwong J; Lo CM; Smedley JG; McClane BA; Aponte M; Gao Z; Sarno JL; Hinners J; Welch WR; Berkowitz RS; Mok SC; Garner EI
    Neoplasia; 2007 Apr; 9(4):304-14. PubMed ID: 17460774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
    Santin AD; Cané S; Bellone S; Palmieri M; Siegel ER; Thomas M; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
    Cancer Res; 2005 May; 65(10):4334-42. PubMed ID: 15899825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines.
    Ogawa M; Kojima T; Someya M; Nomura K; Takasawa A; Murata M; Tanaka S; Saito T; Sawada N
    Histochem Cell Biol; 2012 Aug; 138(2):323-38. PubMed ID: 22544349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for
    Vecchio AJ; Rathnayake SS; Stroud RM
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer.
    Cocco E; Casagrande F; Bellone S; Richter CE; Bellone M; Todeschini P; Holmberg JC; Fu HH; Montagna MK; Mor G; Schwartz PE; Arin-Silasi D; Azoudi M; Rutherford TJ; Abu-Khalaf M; Pecorelli S; Santin AD
    BMC Cancer; 2010 Jul; 10():349. PubMed ID: 20598131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.
    Shang X; Lin X; Alvarez E; Manorek G; Howell SB
    Neoplasia; 2012 Oct; 14(10):974-85. PubMed ID: 23097631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin.
    Gao Z; Xu X; McClane B; Zeng Q; Litkouhi B; Welch WR; Berkowitz RS; Mok SC; Garner EI
    Clin Cancer Res; 2011 Mar; 17(5):1065-74. PubMed ID: 21123456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4.
    Kyuno D; Kojima T; Ito T; Yamaguchi H; Tsujiwaki M; Takasawa A; Murata M; Tanaka S; Hirata K; Sawada N
    Cell Tissue Res; 2011 Dec; 346(3):369-81. PubMed ID: 22160590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
    Shang X; Lin X; Manorek G; Howell SB
    Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
    Uthayanan L; El-Bahrawy M
    J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer.
    Cocco E; Shapiro EM; Gasparrini S; Lopez S; Schwab CL; Bellone S; Bortolomai I; Sumi NJ; Bonazzoli E; Nicoletti R; Deng Y; Saltzman WM; Zeiss CJ; Centritto F; Black JD; Silasi DA; Ratner E; Azodi M; Rutherford TJ; Schwartz PE; Pecorelli S; Santin AD
    Int J Cancer; 2015 Dec; 137(11):2618-29. PubMed ID: 26060989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin-4: A New Molecular Target for Epithelial Cancer Therapy.
    Fujiwara-Tani R; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Kondoh M; Kuniyasu H
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.